Ranibizumab ophthalmic and Vancenase
Determining the interaction of Ranibizumab ophthalmic and Vancenase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: beclomethasone nasal
Brand name: Beconase AQ, QNASL, Beconase, Vancenase, Vancenase AQ, Vancenase AQ DS, QNASL
Synonyms: Beclomethasone nasal, Beclomethasone (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Vancenase AQ
- Ranibizumab ophthalmic-Vancenase AQ Double Strength
- Ranibizumab ophthalmic-Vancocin
- Ranibizumab ophthalmic-Vancocin HCl
- Ranibizumab ophthalmic-Vancocin HCl Pulvules
- Ranibizumab ophthalmic-Vancoled
- Vancenase-Ranitidine
- Vancenase-Ranitidine Capsule
- Vancenase-Ranitidine Hydrochloride
- Vancenase-Ranitidine Injection
- Vancenase-Ranitidine Suspension
- Vancenase-Ranitidine Syrup